GRI Bio, Inc. (GRI)

GRI Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.09	1.81	0.01	3.7	0.11	3.82
Short-Term Investments	0	0	0	3.81	0	0
Cash & Cash Equivalents	4.09	1.81	0.01	7.51	0.11	3.82
Cash Growth	145.71%	19988.89%	-99.88%	6789.91%	-97.15%	523.68%
Other Current Assets	0.34	1.13	0.3	0.62	0.57	0.1
Total Current Assets	4.43	2.93	0.31	8.13	0.67	3.92
Property, Plant & Equipment	0.16	0.02	0.07	0	0	0.35
Other Long-Term Assets	0	0	0	0.21	0.28	0
Total Long-Term Assets	0.16	0.02	0.07	0.21	0.28	0.35
Total Assets	4.59	2.96	0.38	8.34	0.96	4.28
Accounts Payable	0.64	1.41	1.29	0.92	1.23	0.25
Current Debt	0.04	0.01	0.66	0	0.05	0.09
Other Current Liabilities	1	1.27	0.04	1.53	0.95	0.48
Total Current Liabilities	1.68	2.7	1.99	2.45	2.23	0.81
Long-Term Debt	0.11	0	0.01	0	0.01	0.25
Other Long-Term Liabilities	0	0	0	0.07	0.17	0
Total Long-Term Liabilities	0.11	0	0.01	0.07	0.18	0.25
Total Liabilities	1.79	2.7	2.01	2.52	2.41	1.06
Total Debt	0.15	0.01	0.68	0	0.06	0.34
Debt Growth	-	-97.94%	-	-	-82.06%	-
Retained Earnings	-33.42	-31.53	-18.5	-21.9	-12.6	-7.78
Comprehensive Income	0	0	0	-0	0	0
Shareholders' Equity	2.8	0.26	-1.63	5.82	-1.45	3.21
Net Cash / Debt	3.94	1.79	-0.67	7.51	0.05	3.48
Net Cash / Debt Growth	136.58%	-	-	15545.83%	-98.62%	468.19%
Net Cash Per Share	12.41	50.53	-67.42	3134.39	29.07	2677.69
Working Capital	2.75	0.24	-1.68	5.68	-1.55	3.11
Book Value Per Share	8.81	7.29	-163.77	2428.23	-880.88	2471.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).